Global Peptide Nucleic Acid (PNA) Market Growth 2025-2031

Global Peptide Nucleic Acid (PNA) Market Growth 2025-2031


The global Peptide Nucleic Acid (PNA) market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Peptide nucleic acid (PNA) is a synthetic molecule that is similar to DNA and RNA in its structure.The binding affinity and selectivity of PNA towards DNA, RNA is higher than for the analogous DNA duplexes due to the neutral character of PNA. PNA has better discriminating power with a more effective single base mismatch discrimination than DNA.PNA oligomers are resistant to enzymatic degradation by proteases and nucleases, which extends their lifetime for applications in vitro and in vivo. PNAs are also stable over a wide pH range and quite stable under high temperature.

PNA can be used as a specific probe for DNA and RNA for genomics and proteomics research. PNA probes have high specificity and affinity and can accurately detect specific DNA or RNA sequences, so they have broad application prospects in the fields of genetic diagnosis, gene therapy, and gene expression regulation. PNA can also be used as a drug molecule to treat certain diseases. For example, PNA can bind to specific mRNA sequences, thereby preventing its translation into proteins, thereby achieving the purpose of treating diseases. In addition, PNA can also be used as antisense nucleic acid drugs to treat certain genetic diseases and cancers.

LP Information, Inc. (LPI) ' newest research report, the “Peptide Nucleic Acid (PNA) Industry Forecast” looks at past sales and reviews total world Peptide Nucleic Acid (PNA) sales in 2024, providing a comprehensive analysis by region and market sector of projected Peptide Nucleic Acid (PNA) sales for 2025 through 2031. With Peptide Nucleic Acid (PNA) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peptide Nucleic Acid (PNA) industry.

This Insight Report provides a comprehensive analysis of the global Peptide Nucleic Acid (PNA) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Peptide Nucleic Acid (PNA) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Peptide Nucleic Acid (PNA) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peptide Nucleic Acid (PNA) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peptide Nucleic Acid (PNA).

This report presents a comprehensive overview, market shares, and growth opportunities of Peptide Nucleic Acid (PNA) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Labeled PNAs
Unlabeled PNAs

Segmentation by Application:
Gene Probes
Drug Development
Microarrays and Biosensors
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
SBS Genetech
WuXi TIDES
Medtide Inc
HLB panagene
LifeTein
Smartox Biotechnology (SB-PEPTIDE)
LGC Biosearch Technologies
Creative Biogene
Creative Peptides
BOCSCI Inc.
PNA BIO INC
Bio-Synthesis Inc
biomers.net GmbH
DESTINA Genomics Ltd
FASMAC
Allpeptide
Shanghai Science Peptide Biological Technology Co., Ltd.
TAHE-PNA
QiYuebio

Key Questions Addressed in this Report

What is the 10-year outlook for the global Peptide Nucleic Acid (PNA) market?

What factors are driving Peptide Nucleic Acid (PNA) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Peptide Nucleic Acid (PNA) market opportunities vary by end market size?

How does Peptide Nucleic Acid (PNA) break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.


*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
2 Executive Summary
3 Global by Company
4 World Historic Review for Peptide Nucleic Acid (PNA) by Geographic Region
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Manufacturing Cost Structure Analysis
11 Marketing, Distributors and Customer
12 World Forecast Review for Peptide Nucleic Acid (PNA) by Geographic Region
13 Key Players Analysis
14 Research Findings and Conclusion

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings